While the US, Japan and Europe are still the main focus for biopharma firms, improving healthcare standards around the world is driving demand for new biopharmaceutical products in emerging markets.
01-Feb-2017 - Saudi Biotech Manufacturing has selected Swedish engineering firm KeyPlants to design and build a fill/finish plant for biological APIs.
27-Jan-2017 - Donald Trump’s withdrawal from the Trans-Pacific Partnership (TPP) could end up benefitting Asian biosimilar makers and reducing US jobs, says an IP lawyer.
10-Jan-2017 - Sanpower Group says Dendreon's in-house manufacturing set-up will remain in place as it looks to increase US and Asian penetration of the prostate cancer cell therapy.
06-Dec-2016 - A lack of investment and government support has stunted biomanufacturing in India, but Biocon says this will change through the country’s 'Make in India' programme.
01-Nov-2016 - South Korea is a key opportunity for biopharma services firms says Thermo Fisher, reporting its third quarter which saw it up capabilities in the region.
29-Jun-2016 - A recently opened facility will double production of Sanofi Pasteur’s vaccine Stamaril which could alleviate shortages in the wake of recent yellow fever outbreaks in parts of Africa....
28-Jan-2016 - More plants in China will close says a US-based analyst who predicts that some drugmakers' inability to comply with stricter quality rules will create an opportunity for those that can.
22-Jan-2016 - Russia’s first approved trastuzumab biosimilar will be priced at least 10% cheaper than Roche’s Herceptin, according to developer Biocad.
15-Dec-2015 - CSL Behring will target growing Russian demand for protein-based therapies through a new Moscow office but says for now there are no plans for a local manufacturing site.
24-Nov-2015 - Brazilian company Eurofarma claims it has developed Latin America’s first home-grown biosimilar.
06-Nov-2015 - As GE ships the world’s largest ready-made biomanufacturing plant to China, the team involved tells us modular facilities are in demand from southeast Asian governments – and could hold the...
03-Nov-2015 - The $2.4bn market for “unproven” and “unethical” biologics market “preys on vulnerable patients” and harms development of legitimate large molecule drugs, says the International Society for Cellular Therapy (ISCT).
27-Oct-2015 - Soldiers on the battlefield will soon be able to manufacture life-saving biologics in under eight hours using a portable briefcase-sized kit.
08-Sep-2015 - Sanofi’s decision to stop manufacturing an anti-venom will contribute to “needless death and disability” for snake bite victims, according to Médecins Sans Frontières.
19-Aug-2015 - A surge in UK cell therapy production last year means available manufacturing capacity has declined considerably according to a report by Cell Therapy Catapult.
05-Aug-2015 - The European Commission has approved Pfizer’s acquisition of Hospira, providing the larger company first divests of its infliximab candidate and several sterile injectables.
22-Jul-2015 - Novartis expects sales of Afinitor to slow after BMS and Exelixis announced this week their pipeline drugs beat it on renal cell carcinoma.
10-Jul-2015 - We say hello to Baxalta, ask what's the latest in Danaher's $14bn bid for Pall, and look at the latest biotech IPOs in today's Bio-Finance Vision.
23-Jun-2015 - China is set to become a major vaccines manufacturer for emerging markets once it untangles some regulatory quirks, says a panel at BIO 2015.
10-Jun-2015 - The Netherlands and India have signed a MOU (Memorandum of Understanding) under which a government-based institute of the Netherlands will extend technical support for the development and manufacturing of the measles-rubella...
14-Jan-2015 - Thermo Fisher says its $15bn acquisition of Life Technologies last year created cash savings it will pump into a series of aggressive M&As.
19-Dec-2014 - In a reversal from three years ago, the Court of Justice of the European Union (CJEU) ruled on Thursday that an organism incapable of developing into a human being is...
17-Dec-2014 - Indian drugmaker and biosimilars pioneer Biocon has told the Chief Minister of Andhra Pradesh it intends to set up a new biomanufacturing plant.
16-Dec-2014 - Industry heavyweights and Singaporean development groups have unveiled a five-year roadmap to deal with the need for more employees in the fast-growing biologics manufacturing industry on the island.
03-Dec-2014 - Ranbaxy Laboratories has launched the monoclonal antibody Infimab, the first Remicade (Infliximab) biosimilar, in India -- which is the first what could be a few home-grown biosimilar launches.